AC

Andrew Callos

DELAYED 1 MONTH

EVP, Chief Commercial Officer

CYTOKINETICS INC

Filings

9

Companies

1

Latest

Jul 30, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

66
CYTKCLUSTER 2

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$1.1M

14,000 sh

Jul 30 8:26 PM

Jul 30, 2026

—

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Option Exercise

$325.6K

14,000 sh

Jul 30 8:26 PM

Jul 30, 2026

73
CYTKCLUSTER 8

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$1.1M

15,000 sh

Jun 1 10:51 PM

Jun 1, 2026

—

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Option Exercise

$348.9K

15,000 sh

Jun 1 10:51 PM

Jun 1, 2026

71
CYTKCLUSTER 5

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$875.5K

11,333 sh

May 5 8:11 PM

May 5, 2026

—

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Option Exercise

$443.5K

11,333 sh

May 5 8:11 PM

May 5, 2026

58

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$1.0M

15,857 sh

May 4 8:01 PM

May 1, 2026

—

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Option Exercise

$596.7K

15,857 sh

May 4 8:01 PM

May 1, 2026

56

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$948.9K

15,000 sh

Apr 30 8:22 PM

Apr 30, 2026

—

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Option Exercise

$348.9K

15,000 sh

Apr 30 8:22 PM

Apr 30, 2026

60
CYTKCLUSTER 3

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$104.3K

1,709 sh

Mar 16 9:14 PM

Mar 16, 2026

61
CYTKCLUSTER 3

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$156.8K

2,582 sh

Mar 10 10:05 PM

Mar 9, 2026

61
CYTK34% OUT

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Sale

$1.6M

26,000 sh

Mar 5 9:27 PM

Mar 5, 2026

—

CYTOKINETICS INC

Andrew Callos

EVP, Chief Commercial Officer

Option Exercise

$779.3K

26,000 sh

Mar 5 9:27 PM

Mar 5, 2026